Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-15 4:41 pm Unchanged | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management, LLC | 2,220,000 8.120% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:41 pm Purchase | 2025-03-31 | 13G | Altisource Portfolio Solutions S.A. ASPS | Nantahala Capital Management, LLC | 309,664 2.820% | 43,629![]() (+16.40%) | Filing History |
| 2025-05-15 4:40 pm Purchase | 2025-03-31 | 13G | Abeona Therapeutics Inc. ABEO | Nantahala Capital Management, LLC | 4,997,101 9.990% | 570,719![]() (+12.89%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Verastem, Inc. VSTM | Nantahala Capital Management, LLC | 5,459,278 9.990% | 936,094![]() (+20.70%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | BiomX Inc. PHGE | Nantahala Capital Management, LLC | 131,274 9.990% | 36,845![]() (+39.02%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,224,339 9.990% | 136,424![]() (+12.54%) | Filing History |
| 2025-05-15 4:38 pm Unchanged | 2025-03-31 | 13G | Benitec Biopharma Inc. BNTC | Nantahala Capital Management, LLC | 1,038,371 4.390% | 0 (Unchanged) | Filing History |
| 2025-05-15 4:37 pm Purchase | 2025-03-31 | 13G | Third Harmonic Bio, Inc. THRD | Nantahala Capital Management, LLC | 2,938,700 6.520% | 2,938,700![]() (New Position) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Senti Biosciences, Inc. SNTI | Nantahala Capital Management, LLC | 2,220,000 8.120% | 1,710,717![]() (+335.91%) | Filing History |
| 2025-05-15 4:36 pm Purchase | 2025-03-31 | 13G | Avalo Therapeutics, Inc. AVTX | Nantahala Capital Management, LLC | 900,000 8.430% | 900,000![]() (New Position) | Filing History |
| 2025-05-15 4:33 pm Purchase | 2025-03-31 | 13G | Opus Genetics, Inc. IRD | Nantahala Capital Management, LLC | 4,697,656 9.990% | 4,697,656![]() (New Position) | Filing History |
| 2025-05-15 4:32 pm Purchase | 2025-03-31 | 13G | InspireMD, Inc. NSPR | Nantahala Capital Management, LLC | 3,037,935 9.990% | 328,817![]() (+12.14%) | Filing History |
| 2025-05-15 4:31 pm Purchase | 2025-03-31 | 13G | Herbalife Nutrition Ltd. HLF | Nantahala Capital Management, LLC | 5,900,000 5.820% | 5,900,000![]() (New Position) | Filing History |
| 2025-05-07 4:31 pm Purchase | 2025-04-30 | 13G | TELA Bio, Inc. TELA | Nantahala Capital Management, LLC | 5,111,588 12.900% | 1,137,262![]() (+28.62%) | Filing History |
| 2025-04-30 5:15 pm Sale | 2025-03-31 | 13G | Soleno Therapeutics, Inc. SLNO | Nantahala Capital Management, LLC | 2,627,651 5.600% | -1,721,784![]() (-39.59%) | Filing History |
| 2025-04-17 4:31 pm Purchase | 2025-04-10 | 13D | Xtant Medical Holdings, Inc. XTNT | Nantahala Capital Management, LLC | 68,394,000 49.100% | 57,000,000![]() (+500.26%) | Filing History |
| 2025-04-03 5:30 pm Unchanged | 2025-03-31 | 13D | Talphera, Inc. TLPH | Nantahala Capital Management, LLC | 1,992,519 11.700% | 0 (Unchanged) | Filing History |
| 2025-04-02 9:59 pm Unchanged | 2025-03-31 | 13D | Talphera, Inc. TLPH | Nantahala Capital Management, LLC | 1,992,519 11.700% | 0 (Unchanged) | Filing History |
| 2025-03-12 4:30 pm Purchase | 2025-03-10 | 13D | America's Car-Mart, Inc. CRMT | Nantahala Capital Management, LLC | 644,686 7.800% | 100,000![]() (+18.36%) | Filing History |
| 2025-02-19 4:32 pm Purchase | 2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Nantahala Capital Management, LLC | 4,945,209 38.078% | 1,000,000![]() (+25.35%) | Filing History |

